Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets

IntroductionTo further advance our understanding of Muscular Dystrophies (MDs) and Spinocerebellar Ataxias (SCAs), it is necessary to identify the biological patterns associated with disease pathology. Although progress has been made in the fields of genetics and transcriptomics, there is a need for...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Nalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, Darshana Sirisena, Harsha Gunasekara, Athula Dissanayake, Dhammika Amaratunga, Harry W. M. Steinbusch, Yetrib Hathout, Eric P. Hoffman, Ashwin Dalal, Chandra Mohan, K. Ranil D. de Silva
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2025-01-01
Schriftenreihe:	Frontiers in Molecular Neuroscience
Schlagworte:	muscular dystrophy ataxia biomarker DMD LGMD SCA
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fnmol.2024.1482999/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!